Literature DB >> 4064595

Comparison timegadine versus naproxen in rheumatoid arthritis.

M O'Sullivan, M G Molloy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4064595     DOI： 10.1007/BF02031625

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  4 in total

1.  An unusual profile of activity of a new basic anti-inflammatory drug, timegadine.

Authors:  E Bramm; L Binderup; E Arrigoni-Martelli
Journal:  Agents Actions       Date:  1981-07

2.  A new antiinflammatory compound, timegadine (N-cyclohexyl-N"-4-[2-methylquinolyl]-N'-2-thiazolylguanidine), which inhibits both prostaglandin and 12-hydroxyeicosatetraenoic acid (12-HETE) formation.

Authors:  I Ahnfelt-Rønne; E Arrigoni-Martelli
Journal:  Biochem Pharmacol       Date:  1980-12       Impact factor: 5.858

3.  Comparison of timegadine and naproxen in rheumatoid arthritis. A placebo controlled trial.

Authors:  H Berry; B Bloom; L Fernandes; M Morris
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

4.  Timegadine: long-term open study in rheumatoid arthritis.

Authors:  I Caruso; M Fumagalli; F Montrone; M Greco; L Boccassini
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.